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Background
HIV-1 vaccines must induce protective antibodies at
mucosal surfaces; the role of IgA in protection remains
unknown. The HIV-1 Env antibody response begins
~day 17 after transmission, and derives from a polyreac-
tive memory B cell pool of gut flora-reactive IgG1 and
IgA B cells. Whereas the IgG Env antibody response
persists years after acute HIV-1 infection, the initial IgA
response decreases over the first month. There is also
selective destruction of terminal ileum germinal centers
in early HIV-1 infection (EHI). To determine HIV-1 IgA
responses in gut, we isolated Env-reactive antibodies
from ileum from patients in EHI and chronic HIV-1
infection (CHI).
Methods
Single plasma cells (PCs) and IgD- memory B cells were
sorted from the ileum and/or blood of 7 EHI and 3 CHI.
Antibodies were isolated by PCR amplification of Ig heavy
chain V(D)J and light chain VJ genes and characterized by
ELISA and Luminex.
Results
Whereas CHI blood memory IgA+ B cells reactive with
HIV-1 envelope ranged from 0.20-0.79%, only 0-0.07% of
ileum IgA+ B cells were Env-reactive. Of 254 mAbs iso-
lated from EHI ileum, only 3 (1.2%) were HIV-1-reactive.
In CHI, 9 (5.7%) of 158 mAb were HIV-1 reactive. None
of the HIV-1 reactive ileum antibodies were of the IgA
isotype.
Conclusion
HIV-1 envelope reactive IgA+ memory B cells and PCs
can be found in the blood, but there is a dearth of HIV-1
reactive memory IgA+ B cells and PCs in ileum in EHI
and CHI. Loss of IgA in plasma after acute HIV-1 infec-
tion is paralleled by the loss of IgA+ B cells in ileum, and
is likely a consequence of HIV-1-induced ileum germinal
center apoptosis. For vaccine design, it will be important
to determine if mucosal IgA+ B cell loss is due to replicat-
ing virus or is triggered by soluble HIV-1 envelope.
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